Suven Life Sciences Limited (SUVEN.NS) NSE

191.51

-8.68(-4.34%)

Updated at October 17 03:29PM

Currency In INR

Valuation

Market Cap26.67B
Enterprise Value26.29B
P/E Ratio-22.69
PEG Ratio1.56
Price/Sales Ratio555.54
Price/Book Ratio38.01
Enterprise/Revenue555.54
Enterprise/EBITDA-23.39

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-24.51
Operating Margin-25.5

Management Effectiveness

Return On Assets0
Return On Equity-1.22

Income Statement

Revenue66.56M
Revenue/Share0.34
Gross Profit-276.33M
EBITDA-1.55B
Net Income-1.61B
Diluted EPS-7.36

Balance Sheet

Total Cash600.05M
Total Cash/Share0
Total Debt0
Total Debt/Equity0
Current Ratio0
Book Value Per Share5.04

Price History

52-Week Change46.57
52-Week High299.99
52-Week Low102.5
Moving Average 50 Days219.05
Moving Average 200 Days186.56

Statistics

Average Volume149,221
Shares Outstanding218.04M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor217:200
Last Split DateOctober 17, 2022